MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Establishment Labs Holdings Inc

Closed

SectorHealthcare

41.48 3.8

Overview

Share price change

24h

Current

Min

38.06

Max

42.24

Key metrics

By Trading Economics

Income

-18M

-35M

Sales

4.3M

45M

EPS

-1.19

Profit margin

-77.573

Employees

1,018

EBITDA

-19M

-28M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+47.52% upside

Dividends

By Dow Jones

Next Earnings

7 maj 2025

Market Stats

By TradingEconomics

Market Cap

164M

1.2B

Previous open

37.68

Previous close

41.48

News Sentiment

By Acuity

100%

0%

376 / 386 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Establishment Labs Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 paź 2024, 16:43 UTC

Major Market Movers

Establishment Labs Shares Climb on High Demand for FDA-Approved Breast Motiva Implants

27 wrz 2024, 10:33 UTC

Major Market Movers

Establishment Labs Shares Surge Premarket on FDA Breast Implant Approval

Peer Comparison

Price change

Establishment Labs Holdings Inc Forecast

Price Target

By TipRanks

47.52% upside

12 Months Forecast

Average 59.17 USD  47.52%

High 62 USD

Low 54 USD

Based on 6 Wall Street analysts offering 12 month price targets forEstablishment Labs Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

39.83 / 41.75Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

376 / 386 Ranking in Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Establishment Labs Holdings Inc

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.